FDA Inspection 1087733 — Dhaliwal Labs South LLC
The FDA completed an inspection of Dhaliwal Labs South LLC on Apr 25, 2019 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dallas, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 4380 | 21 CFR 211.198(b)(3) | Determination not to conduct investigation of complaint |
| 4402 | 21 CFR 211.192 | Written record of investigation incomplete |